BioNTech SE

BioNTech SE Beats on EPS, Stock Down 3.59%

BioNTech reported a strong earnings per share, beating expectations significantly. However, the stock fell by 3.59% in response, indicating that investors may have had concerns beyond the EPS figure. The lack of revenue data and management commentary may have contributed to the stock's decline.